Strategy
January 2021
Pharma UK: The Transdermal Technology – Compact Case
By Julian Birkinshaw
Pharma UK was the UK subsidiary of Pharma, a major international pharmaceuticals company with expertise in oncology, hormone replacement drugs and fertility. Pharma UK was responsible for selling drugs in the local marketplace. However, it…
January 2021
Building an Agile Organisation at ING Bank Netherlands – Compact Case
By Julian Birkinshaw, Ken Mark
ING Group was established through a merger of three Dutch financial services firms in 1991. It expanded internationally into Europe and the Americas, and created a no-frills savings account business called ING Direct in the…
January 2021
Costa Coffee: Project Marlow – Compact Case
By Julian Birkinshaw, Ken Mark
For Jim Slater, head of Costa Express in 2014, the biggest new growth opportunity was to roll out the company’s third-generation vending machine, called Marlow. The product had been developed in record time, but…
October 2020
COVID-19: Pret a Manger’s Fight for Survival
By Nader Tavassoli, Jessica Spungin
The case describes how Pret a Manger—a London casual-dining institution—was significantly adversely impacted by the COVID-19 pandemic, and how they tried to pivot by launching several business experiments in fast succession. The long-term outcome of…
October 2020
Takeda: The governance of strategic transformation (B) (Japanese)
By Harry Korine, Kazuhiro Asakawa
The case series describes strategic transformation at Takeda, the largest Japanese pharmaceutical company, with a special focus on the R&D function. Since 2015, the 237-year-old industry doyen has narrowed its strategic focus from six to…
October 2020
Takeda: The Governance of Strategic Transformation (A) (Japanese)
By Harry Korine, Kazuhiro Asakawa
The case series describes strategic transformation at Takeda, the largest Japanese pharmaceutical company, with a special focus on the R&D function. Since 2015, the 237-year-old industry doyen has narrowed its strategic focus from six to…
September 2018
David Pyott: The Battle for Allergan (B)
By Randall Peterson, Lisa Duke
This case series charts the evolution of the hostile battle for Allergan and its ultimate sale to a white knight, Actavis. David Pyott had been the CEO of Allergan since January 1998; only the third…
July 2020
Haier’s (2019) ecosystem revolution: From Rendanheyi 2.0 to Rendanheyi 3.0
By Michael Jacobides, Lisa Duke
2019 was an important year for Haier. Its new version of its radically decentralised structure, dubbed Rendanheyi 2.0, based on many independent ‘Ecosystem Micro-enterprise Communities’ (EMCs) had been devised to help it respond to the…
July 2020
Haier’s Rendanheyi 2.0: An ecosystem revolution
By Michael Jacobides, Lisa Duke
Haier in 1984 was a small, local firm on the verge of collapse, with poor-quality products and low morale. Within 30 years, it was transformed by Zhang Ruimin, who took over as CEO, into one…
July 2020
Haier in 2014: An entrepreneurial juggernaut facing a world of platforms and ecosystems
By Michael Jacobides, Lisa Duke
Until the 2010s, China had been known for inexpensive products and efficient, low-cost production and for copycat or OEM products rather than for leading-edge innovation. Yet, in a few short years, Chinese firms turned to…